20-035 Phase II
A Multi-Center, Open Label Phase 1/2 Study of CYT-0851, an Oral RAD51 Inhibitor, in Patients With Relapsed/Refractory B-Cell Malignancies and Advanced Solid Tumors (View details on clinicaltrial.gov)
Search Cancer Clinical Trials
The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
20 results
19-422 Phase I
A Phase 1 First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients with Relapsed or Refractory Acute Myeloid Leukemia (View details on clinicaltrial.gov)
20-560 Phase I
A Phase 1 Study of Oral LY3410738 in Patients with Advanced Hematologic Malignancies with IDH1 or IDH2 Mutations (View details on clinicaltrial.gov)
20-191 Phase I
A Phase 1 Study of SEA-CD70 in Myeloid Malignancies (View details on clinicaltrial.gov)
21-217 Phase I
A PHASE 1, OPEN-LABEL, DOSE-FINDING STUDY OF CC-91633 (BMS-986397) IN SUBJECTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA OR RELAPSED OR REFRACTORY HIGHER-RISK MYELODYSPLASTIC SYNDROMES (View details on clinicaltrial.gov)
21-751 Phase II
A Phase 1/2 Open Label, Multicenter, Dose Escalation and Expansion Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM43239 in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) (View details on clinicaltrial.gov)
14-191 Phase I
A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET Proteins: Phase 1 (Dose Escalation of CPI-0610 in Patients with Hematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 with and without Ruxolitinib in Patients with Myelofibrosis) (View details on clinicaltrial.gov)
22-105 Phase I
A phase 1b, multicenter, open label platform study of select drug combinations in adult patients with lower risk (very low, low, or intermediate risk) myelodysplastic syndrome (View details on clinicaltrial.gov)
21-706 Phase II
A PHASE 1B, OPEN-LABEL, GLOBAL, MULTICENTER, DOSE DETERMINATION STUDY TO EVALUATE SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF CC-486 (ONUREG®) IN COMBINATION THERAPY IN SUBJECTS WITH ACUTE MYELOID LEUKEMIA (AML) (View details on clinicaltrial.gov)
21-113 Phase II
A Phase 2 Randomized Study Comparing Venetoclax and Azacitidine to Induction Chemotherapy for Newly Diagnosed Fit Adults with Acute Myeloid Leukemia (View details on clinicaltrial.gov)
Showing 1 - 10 of 20 results